Journal article · 2025 · Open access
CONSORT 2025 Statement: Updated Guideline for Reporting Randomized Trials
JAMA, 333(22), 1998 · Published 14 April 2025 · DOI 10.1001/jama.2025.4347
In brief
“CONSORT 2025 Statement: Updated Guideline for Reporting Randomized Trials” is a 2025 journal article by Sally Hopewell and 38 co-authors, published in JAMA. OpenAlex counts 476 citations as of 15 November 2026, which puts it in the top 1% of works published in 2025 by citations. It is open access: the full text is free to read at University of Southern Denmark Research Portal (University of Southern Denmark).
- Citations
- 476
- Most cited in
- 2026 (371)
- Field-weighted impact
- 99.31
- References
- 50
- Authors
- 39
Abstract
Importance: Well-designed and properly executed randomized trials are considered the most reliable evidence on the benefits of health care interventions. However, there is overwhelming evidence that the quality of reporting is not optimal. The CONSORT (Consolidated Standards of Reporting Trials) statement was designed to improve the quality of reporting and provides a minimum set of items to be included in a report of a randomized trial. CONSORT was first published in 1996, then updated in 2001 and 2010. Herein, we present the updated CONSORT 2025 statement, which aims to account for recent methodological advancements and feedback from end users. Observations: We conducted a scoping review of the literature and developed a project-specific database of empirical and theoretical evidence related to CONSORT to generate a list of potential changes to the checklist. The list was enriched with recommendations provided by the lead authors of existing CONSORT extensions (harms, outcomes, nonpharmacological treatment), other related reporting guidelines (Template for Intervention Description and Replication [TIDieR]), and recommendations from other sources (eg, personal communications). The list of potential changes to the checklist was assessed in a large, international, online, 3-round Delphi survey involving 317 participants and discussed at a 2-day online expert consensus meeting of 30 invited international experts. We have made substantive changes to the CONSORT checklist. We added 7 new checklist items, revised 3 items, deleted 1 item, and integrated several items from key CONSORT extensions. We also restructured the CONSORT checklist, with a new section on open science. The CONSORT 2025 statement consists of a 30-item checklist of essential items that should be included when reporting the results of a randomized trial and a diagram for documenting the flow of participants through the trial. To facilitate implementation of CONSORT 2025, we have also developed an expanded version of the CONSORT 2025 checklist, with bullet points eliciting critical elements of each item. Conclusions and Relevance: Authors, editors, reviewers, and other potential users should use CONSORT 2025 when writing and evaluating manuscripts of randomized trials to ensure that trial reports are clear and transparent.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Hopewell, S., Chan, A., Collins, P. G. S., Hróbjartsson, A., Moher, D., Schulz, K. F., Tunn, R., Aggarwal, R., Berkwits, M., Berlin, J. A., Bhandari, N., Butcher, N. J., Campbell, M., Chidebe, R. C., Elbourne, D. R., Farmer, A. A., Fergusson, D. A., Golub, R. M., Goodman, S. N., . . . Boutron, I. (2025). CONSORT 2025 Statement: Updated Guideline for Reporting Randomized Trials. JAMA, 333(22), 1998. https://doi.org/10.1001/jama.2025.4347
MLA 9
Hopewell, Sally, et al. “CONSORT 2025 Statement: Updated Guideline for Reporting Randomized Trials.” JAMA, vol. 333, no. 22, 2025, p. 1998. https://doi.org/10.1001/jama.2025.4347.
Chicago
Hopewell, Sally, An‐Wen Chan, Professor Gary S. Collins, Asbjørn Hróbjartsson, David Moher, Kenneth F. Schulz, Ruth Tunn, et al. 2025. “CONSORT 2025 Statement: Updated Guideline for Reporting Randomized Trials.” JAMA 333 (22): 1998. https://doi.org/10.1001/jama.2025.4347.
Harvard
Hopewell, S. et al. (2025) ‘CONSORT 2025 Statement: Updated Guideline for Reporting Randomized Trials’, JAMA, 333(22), p. 1998. doi:10.1001/jama.2025.4347.
IEEE
S. Hopewell et al., “CONSORT 2025 Statement: Updated Guideline for Reporting Randomized Trials,” JAMA, vol. 333, no. 22, p. 1998, 2025, doi: 10.1001/jama.2025.4347.
BibTeX
@article{hopewell2025consort,
title = {{CONSORT 2025 Statement: Updated Guideline for Reporting Randomized Trials}},
author = {Hopewell, Sally and Chan, An‐Wen and Collins, Professor Gary S. and Hróbjartsson, Asbjørn and Moher, David and Schulz, Kenneth F. and Tunn, Ruth and Aggarwal, Rakesh and Berkwits, Michael and Berlin, Jesse A. and Bhandari, Nita and Butcher, Nancy J. and Campbell, Marion and Chidebe, Runcie C.W. and Elbourne, Diana R. and Farmer, Andrew A. and Fergusson, Dean A. and Golub, Robert M. and Goodman, Steven N. and Hoffmann, Tammy and Ioannidis, John P. A. and Kahan, Brennan C and Knowles, Rachel Louise and Lamb, Sarah E and Lewis, Steff C. and Loder, Elizabeth and Offringa, Martin and Ravaud, Philippe and Richards, Dawn P. and Rockhold, Frank W. and others},
journal = {JAMA},
year = {2025},
volume = {333},
number = {22},
pages = {1998},
doi = {10.1001/jama.2025.4347},
url = {https://doi.org/10.1001/jama.2025.4347}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
- reporting guidelines
- trial reporting quality
- CONSORT checklist
- harms reporting
- non-pharmacological treatment
- open science
- TIDieR
- flowcharts
Work with this paper
Most-cited papers in Decision Sciences
- The PRISMA 2020 statement: an updated guideline for reporting systematic reviewsMatthew James Page, Joanne E. McKenzie, Patrick M. Bossuyt and 23 more · BMJ · 2021 · 144,919 citations
- Evaluating Structural Equation Models with Unobservable Variables and Measurement ErrorClaes Fornell, David F. Larcker · Journal of Marketing Research · 1981 · 118,336 citations
- Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternativesLi‐tze Hu, Peter M. Bentler · Structural Equation Modeling A Multidisciplinary Journal · 1999 · 117,461 citations
- Common method biases in behavioral research: A critical review of the literature and recommended remedies.Philip M. Podsakoff, SCOTT B. MACKENZIE, Jeong Yeon Lee and 1 more · Journal of Applied Psychology · 2003 · 89,248 citations
- Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statementDavid Moher, Alessandro Liberati, Jennifer Tetzlaff and 2 more · BMJ · 2009 · 85,524 citations
Questions about this paper
How do I cite this paper in APA style?
Hopewell, S., Chan, A., Collins, P. G. S., Hróbjartsson, A., Moher, D., Schulz, K. F., Tunn, R., Aggarwal, R., Berkwits, M., Berlin, J. A., Bhandari, N., Butcher, N. J., Campbell, M., Chidebe, R. C., Elbourne, D. R., Farmer, A. A., Fergusson, D. A., Golub, R. M., Goodman, S. N., . . . Boutron, I. (2025). CONSORT 2025 Statement: Updated Guideline for Reporting Randomized Trials. JAMA, 333(22), 1998. https://doi.org/10.1001/jama.2025.4347
How many times has this paper been cited?
476 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access: read the free full text at University of Southern Denmark Research Portal (University of Southern Denmark).
Who wrote this paper?
Sally Hopewell, An‐Wen Chan, Professor Gary S. Collins, Asbjørn Hróbjartsson, David Moher, Kenneth F. Schulz, Ruth Tunn, Rakesh Aggarwal, Michael Berkwits, Jesse A. Berlin, Nita Bhandari, Nancy J. Butcher and 27 more.
What is the DOI of this paper?
10.1001/jama.2025.4347. The permanent link is https://doi.org/10.1001/jama.2025.4347.
Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.